Endometrial cancer treatment market to see ‘significant’ growth by 2034: report

It is being driven by ageing populations, increases in obesity, and metabolic conditions.

The endometrial cancer treatment market is expected to grow significantly by 2034, according to a DelveInsight report.

The report said it is being driven by ageing populations, increases in obesity, and metabolic conditions in many regions.

Recent regulatory approvals and label expansions are adding higher-cost, high-value therapeutic options, accelerating uptake and market spending.

Still, the primary treatment for endometrial cancer remains hysterectomy. However, in recent years, several drugs have gained regulatory clearance in the US for treating this disease.